Hereditary dysautonomias: Current knowledge and collaborations for the future
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Hereditary dysautonomias : Current knowledge and collaborations for the future. / Cuajungco, Math P.; Ando, Yukio; Axelrod, Felicia B.; Biaggioni, Italo; Goldstein, David S.; Guttmacher, Alan E.; Gwinn-Hardy, Katrina; Hahn, Maureen K.; Hilz, Max J.; Jacob, Giris; Jens, Jordan; Kennedy, William R.; Liggett, Stephen B.; O'Connor, Daniel T.; Peltzer, Sonia R.; Robertson, David; Rubin, Berish Y.; Scudder, Quandra; Smith, Linda J.; Sonenshein, Gail E.; Svejstrup, Jesper Q.; Xu, Yang; Slaugenhaupt, Susan A.
In: Clinical Autonomic Research, Vol. 13, No. 3, 2003, p. 180-195.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Hereditary dysautonomias
T2 - Current knowledge and collaborations for the future
AU - Cuajungco, Math P.
AU - Ando, Yukio
AU - Axelrod, Felicia B.
AU - Biaggioni, Italo
AU - Goldstein, David S.
AU - Guttmacher, Alan E.
AU - Gwinn-Hardy, Katrina
AU - Hahn, Maureen K.
AU - Hilz, Max J.
AU - Jacob, Giris
AU - Jens, Jordan
AU - Kennedy, William R.
AU - Liggett, Stephen B.
AU - O'Connor, Daniel T.
AU - Peltzer, Sonia R.
AU - Robertson, David
AU - Rubin, Berish Y.
AU - Scudder, Quandra
AU - Smith, Linda J.
AU - Sonenshein, Gail E.
AU - Svejstrup, Jesper Q.
AU - Xu, Yang
AU - Slaugenhaupt, Susan A.
N1 - Funding Information: ■ Acknowledgments We thank the org anizers of the first workshop in dysautonomia for making it a success. Funding for the H-Dys Workshop was provided by the NINDS and the ORD, NIH. We thank Ms. Debra Kulik and Ms. Lee May for their help. We are also g rateful to the Dysautonomia Foundation, Inc., the Familial Dysautonomia Hope Foundation, and the National Dysautonomia Research Foundation for their continued financial support in all areas of dysautonomia research.
PY - 2003
Y1 - 2003
N2 - The hereditary dysautonomias (H-Dys) are a large group of disorders that affect the autonomic nervous system. Research in the field of H-Dys is very challenging, because the disorders involve interdisciplinary, integrative, and "mind-body" connections. Recently, medical scientists, NIH/ NINDS representatives, and several patient support groups gathered for the first time in order to discuss recent findings and future directions in the H-Dys field. The H-Dys workshop was instrumental in promoting interactions between basic science and clinical investigators. It also allowed attendees to have an opportunity to meet each other, understand the similarities between the various forms of dysautonomia, and experience the unique perspective offered by patients and their families. Future advances in H-Dys research will depend on a novel multi-system approach by investigators from different medical disciplines, and it is hoped that towards a common goal, novel "bench-to-bedside" therapeutics will be developed to improve the lives of, or even cure, patients suffering from dysautonomic syndromes.
AB - The hereditary dysautonomias (H-Dys) are a large group of disorders that affect the autonomic nervous system. Research in the field of H-Dys is very challenging, because the disorders involve interdisciplinary, integrative, and "mind-body" connections. Recently, medical scientists, NIH/ NINDS representatives, and several patient support groups gathered for the first time in order to discuss recent findings and future directions in the H-Dys field. The H-Dys workshop was instrumental in promoting interactions between basic science and clinical investigators. It also allowed attendees to have an opportunity to meet each other, understand the similarities between the various forms of dysautonomia, and experience the unique perspective offered by patients and their families. Future advances in H-Dys research will depend on a novel multi-system approach by investigators from different medical disciplines, and it is hoped that towards a common goal, novel "bench-to-bedside" therapeutics will be developed to improve the lives of, or even cure, patients suffering from dysautonomic syndromes.
KW - Amyloidosis
KW - Autonomic nervous system
KW - Catecholamine
KW - Neuropathy
U2 - 10.1007/s10286-003-0098-2
DO - 10.1007/s10286-003-0098-2
M3 - Journal article
C2 - 12822040
AN - SCOPUS:10744228001
VL - 13
SP - 180
EP - 195
JO - Clinical Autonomic Research
JF - Clinical Autonomic Research
SN - 0959-9851
IS - 3
ER -
ID: 331041107